BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38281894)

  • 21. Catheter position prediction using deep-learning-based multi-atlas registration for high-dose rate prostate brachytherapy.
    Lei Y; Wang T; Fu Y; Roper J; Jani AB; Liu T; Patel P; Yang X
    Med Phys; 2021 Nov; 48(11):7261-7270. PubMed ID: 34480801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
    Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Derivation of in vivo source tracking error thresholds for TRUS-based HDR prostate brachytherapy through simulation of source positioning errors.
    Poder J; Carrara M; Howie A; Cutajar D; Bucci J; Rosenfeld A
    Brachytherapy; 2019; 18(5):711-719. PubMed ID: 31175015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dwell time modulation restrictions do not necessarily improve treatment plan quality for prostate HDR brachytherapy.
    Balvert M; Gorissen BL; den Hertog D; Hoffmann AL
    Phys Med Biol; 2015 Jan; 60(2):537-48. PubMed ID: 25549084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bi-objective optimization of catheter positions for high-dose-rate prostate brachytherapy.
    van der Meer MC; Bosman PAN; Niatsetski Y; Alderliesten T; van Wieringen N; Pieters BR; Bel A
    Med Phys; 2020 Dec; 47(12):6077-6086. PubMed ID: 33000874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of the dwell time deviation constraint (DTDC) parameter on dosimetry with IPSA optimisation for HDR prostate brachytherapy.
    Smith RL; Panettieri V; Lancaster C; Mason N; Franich RD; Millar JL
    Australas Phys Eng Sci Med; 2015 Mar; 38(1):55-61. PubMed ID: 25481387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of a 2D diode array in “magic phantom” for use in high dose rate brachytherapy pretreatment quality assurance.
    Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfelda AB
    Med Phys; 2015 Feb; 42(2):663-73. PubMed ID: 25771556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D dose reconstruction based on in vivo dosimetry for determining the dosimetric impact of geometric variations in high-dose-rate prostate brachytherapy.
    Jørgensen EB; Buus S; Bentzen L; Hokland SB; Rylander S; Kertzscher G; Beddar S; Tanderup K; Johansen JG
    Radiother Oncol; 2022 Jun; 171():62-68. PubMed ID: 35033604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric performance of a multipoint plastic scintillator dosimeter as a tool for real-time source tracking in high dose rate
    Linares Rosales HM; Archambault L; Beddar S; Beaulieu L
    Med Phys; 2020 Sep; 47(9):4477-4490. PubMed ID: 32443175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the dosimetric coverage of interstitial high-dose-rate breast implants.
    Kestin LL; Jaffray DA; Edmundson GK; Martinez AA; Wong JW; Kini VR; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):35-43. PubMed ID: 10656370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance.
    Guiral P; Ribouton J; Jalade P; Wang R; Galvan JM; Lu GN; Pittet P; Rivoire A; Gindraux L
    Med Phys; 2016 Sep; 43(9):5240. PubMed ID: 27587055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel system for commissioning brachytherapy applicators: example of a ring applicator.
    Fonseca GP; Van den Bosch MR; Voncken R; Podesta M; Verhaegen F
    Phys Med Biol; 2017 Oct; 62(21):8360-8375. PubMed ID: 28914613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive error detection for HDR/PDR brachytherapy: guidance for decision making during real-time in vivo point dosimetry.
    Kertzscher G; Andersen CE; Tanderup K
    Med Phys; 2014 May; 41(5):052102. PubMed ID: 24784391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dwell time verification in brachytherapy based on time resolved in vivo dosimetry.
    Johansen JG; Kertzscher G; Jørgensen EB; Rylander S; Bentzen L; Hokland SB; Søndergaard CS; With AKM; Buus S; Tanderup K
    Phys Med; 2019 Apr; 60():156-161. PubMed ID: 31000077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter reconstruction and dosimetric verification of MRI-only treatment planning (MRTP) for interstitial HDR brachytherapy using PETRA sequence.
    Lee CY; Kaza E; Harris TC; O'Farrell DA; King MT; Dyer MA; Cormack RA; Buzurovic I
    Phys Med Biol; 2023 Jan; 68(3):. PubMed ID: 36584396
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo dose verification method in catheter based high dose rate brachytherapy.
    Jaselskė E; Adlienė D; Rudžianskas V; Urbonavičius BG; Inčiūra A
    Phys Med; 2017 Dec; 44():1-10. PubMed ID: 29254585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brachytherapy treatment verification using gamma radiation from the internal treatment source combined with an imaging panel-a phantom study.
    Fonseca GP; van Wagenberg T; Voncken R; Podesta M; van Beveren C; van Limbergen E; Lutgens L; Vanneste B; Berbee M; Reniers B; Verhaegen F
    Phys Med Biol; 2021 May; 66(10):. PubMed ID: 33831856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First pointwise encoding time reduction with radial acquisition (PETRA) implementation for catheter detection in interstitial high-dose-rate (HDR) brachytherapy.
    Kaza E; Lee CY; King MT; Dyer MA; Cormack RA; Buzurovic I
    Brachytherapy; 2022; 21(4):501-510. PubMed ID: 35337748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
    Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
    Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scintillation dosimeter with real-time positional tracking information for in vivo dosimetry error detection in HDR brachytherapy.
    Tho D; Lavallée MC; Beaulieu L
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14150. PubMed ID: 37731203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.